Carevive was selected from a field of contestants because of their experience with oncology providers and patients, as well as with value-based healthcare. Carevive’s platform includes remote symptom monitoring and clinical decision support features, and helps healthcare providers include the patient voice in treatment decisions with improved outcomes. The Pfizer PRO Challenge is designed to identify innovative PRO-based platforms and technologies that can provide novel patient-centric support & insight mechanisms for cancer patients.
This is an example of how our digital portfolio is making healthcare more patient-centric and working to reduce costs at the same time as improving outcomes. Remote monitoring is even more important for cancer patients at the moment because Covid-19 is limiting visits to the healthcare providers.
You can access the full press release here.